A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.

This study shows that reduced protein and mRNA levels of MAP2K4 found in PDAC patients, coupled to in vitro effects observed, support the tumor suppressor role of MAP2K4 in PDAC. Importantly, combining MAP2K4 and JNK expression with the TNM staging system results in a better prediction of postoperative survival of patients with PDAC. PMID: 33341545 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33341545?dopt=Abstract

Source: Pathology, Research and Practice - December 4, 2020 Category: Pathology Authors: Liu XD, Zhang ZW, Wu HW, Liang ZY Tags: Pathol Res Pract Source Type: research